These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22342435)

  • 1. Recurrent seizures in a levetiracetam-treated patient after subarachnoid hemorrhage: a matter of enhanced renal function?
    Drust A; Luchtmann M; Firsching R; Tröger U; Martens-Lobenhoffer J; Bode-Böger SM
    Epilepsy Behav; 2012 Mar; 23(3):394-5. PubMed ID: 22342435
    [No Abstract]   [Full Text] [Related]  

  • 2. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
    Mink S; Muroi C; Seule M; Bjeljac M; Keller E
    Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiepileptic drugs in aneurysmal subarachnoid hemorrhage.
    Zubkov AY; Wijdicks EF
    Rev Neurol Dis; 2008; 5(4):178-81. PubMed ID: 19122570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam-induced interstitial nephritis in a patient with glioma.
    Mahta A; Kim RY; Kesari S
    J Clin Neurosci; 2012 Jan; 19(1):177-8. PubMed ID: 22071460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encephalopathy induced by levetiracetam in an elderly woman.
    Hommet C; Beaufils E; Roubeau V; De Toffol B; Ripault H; Constans T; Mondon K
    Aging Clin Exp Res; 2013 Apr; 25(1):111-3. PubMed ID: 23740641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.
    Spencer DD; Jacobi J; Juenke JM; Fleck JD; Kays MB
    Pharmacotherapy; 2011 Oct; 31(10):934-41. PubMed ID: 21950640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-drug interaction between methotrexate and levetiracetam in a child treated for acute lymphoblastic leukemia.
    Parentelli AS; Phulpin-Weibel A; Mansuy L; Contet A; Trechot P; Chastagner P
    Pediatr Blood Cancer; 2013 Feb; 60(2):340-1. PubMed ID: 23129570
    [No Abstract]   [Full Text] [Related]  

  • 8. Status gelasticus associated with levetiracetam as add-on treatment.
    Pustorino G; Spano M; Sgro DL; Di Rosa G; Tricomi G; Bellantone D; Tortorella G
    Epileptic Disord; 2007 Jun; 9(2):186-9. PubMed ID: 17525032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam-induced platelet dysfunction.
    Hacquard M; Richard S; Lacour JC; Lecompte T; Vespignani H
    Epilepsy Res; 2009 Sep; 86(1):94-6. PubMed ID: 19447009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome induced by levetiracetam.
    Zou LP; Ding CH; Song ZJ; Li XF
    Seizure; 2012 Dec; 21(10):823-5. PubMed ID: 23036769
    [No Abstract]   [Full Text] [Related]  

  • 11. Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies.
    Caraballo RH; Cersósimo R; De los Santos C
    Epileptic Disord; 2010 Jun; 12(2):146-50. PubMed ID: 20483715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam, seizures, and suicidality.
    Givon L; Porter S; Padmanabhan B; Goren J; Cohen PA
    Harv Rev Psychiatry; 2011; 19(1):47-55. PubMed ID: 21250896
    [No Abstract]   [Full Text] [Related]  

  • 13. Acceptability and tolerability of levetiracetam oral solution for the treatment of partial-onset seizures: the SOLUCIÓN study.
    Matías-Guíu J; Molins A; Mauri JA; Villar E
    Methods Find Exp Clin Pharmacol; 2010 Sep; 32(7):507-16. PubMed ID: 21069102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytopenia during levetiracetam therapy.
    Meschede A; Runge U; Sabolek M
    Epilepsy Res; 2008 Jul; 80(1):91-2. PubMed ID: 18424076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam-associated Hypokalemia and Hypomagnesaemia among Two Patients Treated for Seizures.
    Vallianou NG; Geladari E; Chroni P; Kokkinakis E
    CNS Neurosci Ther; 2015 Jun; 21(6):539. PubMed ID: 25899700
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversible panhypogammaglobulinemia associated with the antiepileptic agent levetiracetam.
    Azar AE; Ballas ZK
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):108-9. PubMed ID: 18681095
    [No Abstract]   [Full Text] [Related]  

  • 17. Levetiracetam and psychosis.
    Rodríguez-Toledo S; Trebbau-López H; Reyes-Molón L; del Río-Vega J
    Actas Esp Psiquiatr; 2012; 40(1):49. PubMed ID: 22344497
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonepileptic seizures under levetiracetam therapy.
    Ignatenco A; Arzy S; Ghika J; Genoud D; Kaplan PW; Groppa S; Seeck M
    Epilepsy Behav; 2010 Nov; 19(3):526-7. PubMed ID: 20934390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic elevation of liver enzymes due to levetiracetam: a case report.
    Sethi NK; Sethi PK; Torgovnick J; Arsura E; Cukierwar F
    Drug Metabol Drug Interact; 2013; 28(2):123-4. PubMed ID: 23420283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.